| General design Bayesian generalized linear mixed models Y Zhao, J Staudenmayer, BA Coull, MP Wand Statistical science, 35-51, 2006 | 261 | 2006 |
| Phase I open-label study of continuous treatment with BIBF 1120, a triple angiokinase inhibitor, and pemetrexed in pretreated non–small cell lung cancer patients PM Ellis, R Kaiser, Y Zhao, P Stopfer, S Gyorffy, N Hanna Clinical Cancer Research 16 (10), 2881-2889, 2010 | 119 | 2010 |
| Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer LWC Chow, B Xu, S Gupta, A Freyman, Y Zhao, R Abbas, ML Vo Van, ... British journal of cancer 108 (10), 1985-1993, 2013 | 99 | 2013 |
| A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with … RC Doebele, P Conkling, AM Traynor, GA Otterson, Y Zhao, S Wind, ... Annals of oncology 23 (8), 2094-2102, 2012 | 92 | 2012 |
| Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study WW Fleischhacker, J Podhorna, M Gröschl, S Hake, Y Zhao, S Huang, ... The Lancet Psychiatry 8 (3), 191-201, 2021 | 78 | 2021 |
| A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors MS Gordon, DS Mendelson, M Gross, M Uttenreuther-Fischer, ... Investigational new drugs 31, 409-416, 2013 | 43 | 2013 |
| The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies M Ichinose, H Taniguchi, A Takizawa, L Grönke, L Loaiza, F Voß, Y Zhao, ... International Journal of Chronic Obstructive Pulmonary Disease, 2017-2027, 2016 | 40 | 2016 |
| Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary … F Maltais, D O’Donnell, JB Gáldiz Iturri, AM Kirsten, D Singh, A Hamilton, ... Therapeutic Advances in Respiratory Disease 12, 1753465818755091, 2018 | 37 | 2018 |
| P250 Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPD F Maltais, JBG Iturri, A Kirsten, D Singh, A Hamilton, K Tetzlaff, Y Zhao, ... Thorax 69 (Suppl 2), A186-A187, 2014 | 33 | 2014 |
| Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study M Ichinose, M Nishimura, M Akimoto, Y Kurotori, Y Zhao, A de la Hoz, ... International Journal of Chronic Obstructive Pulmonary Disease, 2147-2156, 2018 | 26 | 2018 |
| Safety and Efficacy of Neratinib (HKI-272) in Combination with Paclitaxel in ErbB2+ Metastatic Breast Cancer. L Chow, S Gupta, D Hershman, Z Jiang, R Epstein, I Bondarenko, ... Cancer Research 69 (24_Supplement), 5081-5081, 2009 | 25 | 2009 |
| Statistical inference based on non-smooth estimating functions L Tian, J Liu, Y Zhao, LJ Wei Biometrika 91 (4), 943-954, 2004 | 25 | 2004 |
| Phase I first-in-man trial of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (Pts) with advanced solid tumors. PG Aftimos, O Bechter, A Awada, C Jungels, H Dumez, N Huyvaert, ... Journal of Clinical Oncology 35 (15_suppl), 2504-2504, 2017 | 20 | 2017 |
| Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic … R Aalbers, MR Maleki-Yazdi, A Hamilton, S Waitere-Wijker, Y Zhao, ... Advances in Therapy 32, 809-822, 2015 | 19 | 2015 |
| Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease C Bai, M Ichinose, SH Lee, KH Lee, O Jöns, U Bothner, Y Zhao, R Buhl International Journal of Chronic Obstructive Pulmonary Disease, 3329-3339, 2017 | 16 | 2017 |
| 987P Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study M Wang, JCH Yang, P Mitchell, J Fang, W Nian, CH Chiu, J Zhou, Y Zhao, ... Annals of Oncology 33, S1003-S1004, 2022 | 14 | 2022 |
| OA15. 02 Phase 1 studies of DZD9008, an oral selective EGFR/HER2 inhibitor in advanced NSCLC with EGFR exon20 insertion mutations P Janne, M Wang, P Mitchell, J Fang, W Nian, C Chiu, J Zhou, Y Zhao, ... Journal of Thoracic Oncology 16 (10), S874, 2021 | 14 | 2021 |
| Safety and efficacy of neratinib (HKI-272) in combination with paclitaxel in patients with solid tumors L Chow, Z Jiang, R Epstein, I Bondarenko, A Awada, C Coughlin, ... Journal of Clinical Oncology 27 (15_suppl), 3557-3557, 2009 | 13 | 2009 |
| Pharmacokinetic (PK) analysis of a phase I study of continuous oral treatment with the angiokinase inhibitor BIBF 1120, in combination with carboplatin and paclitaxel in … DR Camidge, P Conkling, JJ Stephenson, PM Glassman, Y Zhao, ... Journal of Clinical Oncology 26 (15_suppl), 3567-3567, 2008 | 13 | 2008 |
| Discussion of nonparametric and semiparametric regression W Guo, P Hall, J Harezlak, J Huang, A Kneip, X Lin, J Morris, M Pourmadi, ... Statistica Sinica 14, 615-629, 2004 | 9 | 2004 |
